If approved, the pill is expected to be far easier to administer than current injectables—and far easier to manufacture ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift ... Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York.

Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1458 ET – Eli Lilly’s LillyDirect expansion is a positive step as access to adequate providers remains a barrier ...

The trial results are among the pharmaceutical industry's most critical and closely watched of the year, as they bring Eli Lilly's drug one ... for UC San Diego's Center for Advanced Weight ...